Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

NGK's Chip-type Ceramic Secondary Batteries, "EnerCera Pouch" ...

NAGOYA, Japan, Dec. 14, 2018 /Kyodo JBN- AsiaNet/ -- NGK INSULATORS, LTD. (hereinafter "NGK") based in Nagoya, Japan, announced that it has been named a CES (R) 2019 Innovation Awards honore...

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media Out...

Michter's to Release US*1 Barrel Strength Rye

LOUISVILLE, Kentucky, Mar. 20, 2019 /PRNewswire-AsiaNet/-- The Louisville based distiller will be releasing its Michter's US*1 Barrel Strength Kentucky Straight Rye Whiskey this April 2019.P...

Moonstake Partners with Sylo to bring their Staking Ecosystem to the Sylo Smart Wallet

SINGAPORE, Apr 9, 2021 - (ACN Newswire) - Moonstake is proud to announce the beginning of a strategic partnership with Sylo, a decentralised software development firm and the creators of th...

Suning.com listed on 2018 Fortune Global 500 with profit growt...

NANJING, China, July 24, 2018 /PRNewswire-AsiaNet/ -- Suning.com, a subsidiary of Suning Holdings Group ("Suning") was listed on 2018 Fortune Global 500 with an annual revenue of USD 27.8 bi...

Chin Hin Group Property to acquire 45% stake in Aima Construction for RM31.5 million

KUALA LUMPUR, Mar 10, 2021 - (ACN Newswire) - Chin Hin Group Property Berhad (CHGP; 7187), a Bursa Main Market listed company primarily involved in assembly and sales of new and rebuilt com...

Shop, Save, and Celebrate in Singapore with the Great iShopChangi Sale Father’s Day Steals

Gear up for a month of mega savings with the Great iShopChangi Sale running till 30 June! Discover unbeatable deals on top-tier tech, luxury liquors, fashionable finds, and beauty bests, all...

De Beers Group Celebrates Return of the Iconic A Diamond is Forever Tagline With Nature’s Mic Drop Art Exhibition Curated by SEEFOOD ROOM

Actor Janice Man appointed as Natural Diamond Ambassador HONG KONG SAR - Media OutReach Newswire - 6 December 2023 - De Beers Group has always been a pioneer in the natural diamond industry...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 5, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "eribulin") will be presented during the 42nd San Antonio Breast Cancer Symposium (SABCS2019). The symposium will be held from December 10 through 14, 2019, in San Antonio, Texas in the United States.

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

A total of five poster presentations will be given at this year's SABCS including the study results evaluating absolute lymphocyte count at the baseline with eribulin as a predictor of overall survival from the post-hoc analysis of two Phase III clinical studies of eribulin in patients with advanced or metastatic breast cancer.Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. Eisai will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.

Contact:Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastStreamEastjojobetcialis 20 mg fiyat